Abstract

PurposeTo evaluate the diagnostic performance of cerebral blood flow (CBF) by using arterial spin labeling (ASL) perfusion magnetic resonance (MR) imaging to differentiate glioblastoma (GBM) from brain metastasis.Materials and MethodsThe institutional review board of our hospital approved this retrospective study. The study population consisted of 128 consecutive patients who underwent surgical resection and were diagnosed as either GBM (n = 89) or brain metastasis (n = 39). All participants underwent preoperative MR imaging including ASL. For qualitative analysis, the tumors were visually graded into five categories based on ASL-CBF maps by two blinded reviewers. For quantitative analysis, the reviewers drew regions of interest (ROIs) on ASL-CBF maps upon the most hyperperfused portion within the tumor and upon peritumoral T2 hyperintensity area. Signal intensities of intratumoral and peritumoral ROIs for each subject were normalized by dividing the values by those of contralateral normal gray matter (nCBFintratumoral and nCBFperitumoral, respectively). Visual grading scales and quantitative parameters between GBM and brain metastasis were compared. In addition, the area under the receiver-operating characteristic curve was used to evaluate the diagnostic performance of ASL-driven CBF to differentiate GBM from brain metastasis.ResultsFor qualitative analysis, GBM group showed significantly higher grade compared to metastasis group (p = 0.001). For quantitative analysis, both nCBFintratumoral and nCBFperitumoral in GBM were significantly higher than those in metastasis (both p < 0.001). The areas under the curve were 0.677, 0.714, and 0.835 for visual grading, nCBFintratumoral, and nCBFperitumoral, respectively (all p < 0.001).ConclusionASL perfusion MR imaging can aid in the differentiation of GBM from brain metastasis.

Highlights

  • Differentiation of glioblastomas (GBMs) from brain metastases is clinically important, because these two entities differ from each other in clinical course and management

  • Regarding dynamic susceptibility contrast-enhanced (DSC) perfusion imaging, several studies have demonstrated that relative cerebral blood volume in the peritumoral T2 hyperintensity area in GBM is significantly higher than that in brain metastasis

  • GBMs exhibited higher cerebral blood flow (CBF) values based on arterial spin labeling (ASL) perfusion magnetic resonance (MR) imaging using both qualitative and quantitative approaches

Read more

Summary

Introduction

Differentiation of glioblastomas (GBMs) from brain metastases is clinically important, because these two entities differ from each other in clinical course and management. For patients without proven systemic malignancy, differentiation of brain metastasis from high grade glioma such as GBM becomes challenging because they are known to exhibit overlapping imaging findings on conventional magnetic resonance (MR) imaging [1, 2]. Both GBMs and metastatic brain tumors are known to induce angiogenesis, and display increased perfusion [3]. Regarding dynamic susceptibility contrast-enhanced (DSC) perfusion imaging, several studies have demonstrated that relative cerebral blood volume (rCBV) in the peritumoral T2 hyperintensity area in GBM is significantly higher than that in brain metastasis. RCBV measurement in enhancing tumor volumes using DSC perfusion imaging has not been shown to be helpful in the differentiation of the two [1, 2, 8,9,10, 12]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call